Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis. [electronic resource]
Producer: 20040902Description: 5940-7 p. digitalISSN:- 0022-1767
- Animals
- Bone Marrow Cells -- cytology
- Carrier Proteins -- antagonists & inhibitors
- Cell Differentiation -- drug effects
- Cell Line
- Coated Pits, Cell-Membrane -- drug effects
- Curcumin -- pharmacology
- Enzyme Inhibitors -- pharmacology
- Growth Inhibitors -- pharmacology
- I-kappa B Kinase
- I-kappa B Proteins -- antagonists & inhibitors
- Macrophages -- cytology
- Membrane Glycoproteins -- antagonists & inhibitors
- Mice
- NF-KappaB Inhibitor alpha
- NF-kappa B -- antagonists & inhibitors
- Osteoclasts -- cytology
- Phosphorylation -- drug effects
- Protein Serine-Threonine Kinases -- antagonists & inhibitors
- RANK Ligand
- Receptor Activator of Nuclear Factor-kappa B
- Signal Transduction -- drug effects
- Stem Cells -- cytology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.